Cargando…

Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549

Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Ekta, Tripathi, Vinay, Kumar, Vivek, Juyal, Vijay, Bhagat, Sunita, Ram, Veerma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989918/
https://www.ncbi.nlm.nih.gov/pubmed/24748738
http://dx.doi.org/10.4103/0971-6580.128800
_version_ 1782312204847022080
author Kapoor, Ekta
Tripathi, Vinay
Kumar, Vivek
Juyal, Vijay
Bhagat, Sunita
Ram, Veerma
author_facet Kapoor, Ekta
Tripathi, Vinay
Kumar, Vivek
Juyal, Vijay
Bhagat, Sunita
Ram, Veerma
author_sort Kapoor, Ekta
collection PubMed
description Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made toward the development of target specific and cost-effective antimicrobial agents against MDR-M. tuberculosis. However, the drugs in use are still incapable of controlling the upsurge of MDR. Thus, in order to address the issue, we synthesized a library of symmetrical trans-cyclohexane-1, 4-diamine derivatives and evaluated their anti-mycobacterium activity in H(37)RV strain of M. tuberculosis. A range of efficacy has been recorded in different derivatives of synthesized compounds and compound “9u” having i-propyl group substitution at p-position, was found to have more significant detrimental effects against the tested strain of M. tuberculosis. The present investigations were aimed to study whether the effective anti-mycobacterium concentrations of “9u” are biologically safe to human cells or not? The human lung epithelial cell line-A549 were exposed to a range of concentrations, i.e., at and above the anti-mycobacterium effective dose of “9u” for a period of 0-96 h. The standard endpoints of cytotoxicity viz., tetrazolium bromide salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), neutral red uptake, lactate dehydrogenase release, trypan blue dye exclusion assays; and genotoxicity viz., micronucleus and chromosomal aberrations assays were used to evaluate the bio-safety of test compound. The compound “9u” shows no significant cytotoxicity and genotoxicity in A549 cells exposed to 10(-5) M for 72 h, a concentration substantially higher than the concentration kill the H(37)Rv strain of M. tuberculosis. The compound 9u was found to be safe up to 10(-4) M if given for 24 h. The data reveal the therapeutic potential of compound 9u against M. tuberculosis without any having any cytotoxicity and genotoxicity responses.
format Online
Article
Text
id pubmed-3989918
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39899182014-04-18 Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549 Kapoor, Ekta Tripathi, Vinay Kumar, Vivek Juyal, Vijay Bhagat, Sunita Ram, Veerma Toxicol Int Original Article Increasing incidences of multiple drug-resistance (MDR) in Mycobacterium tuberculosis are emerging as one among the serious public health threats and socio-economic burden to the third world countries including India. Last couples of decades are witnesses of the dedicated and sustained efforts made toward the development of target specific and cost-effective antimicrobial agents against MDR-M. tuberculosis. However, the drugs in use are still incapable of controlling the upsurge of MDR. Thus, in order to address the issue, we synthesized a library of symmetrical trans-cyclohexane-1, 4-diamine derivatives and evaluated their anti-mycobacterium activity in H(37)RV strain of M. tuberculosis. A range of efficacy has been recorded in different derivatives of synthesized compounds and compound “9u” having i-propyl group substitution at p-position, was found to have more significant detrimental effects against the tested strain of M. tuberculosis. The present investigations were aimed to study whether the effective anti-mycobacterium concentrations of “9u” are biologically safe to human cells or not? The human lung epithelial cell line-A549 were exposed to a range of concentrations, i.e., at and above the anti-mycobacterium effective dose of “9u” for a period of 0-96 h. The standard endpoints of cytotoxicity viz., tetrazolium bromide salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), neutral red uptake, lactate dehydrogenase release, trypan blue dye exclusion assays; and genotoxicity viz., micronucleus and chromosomal aberrations assays were used to evaluate the bio-safety of test compound. The compound “9u” shows no significant cytotoxicity and genotoxicity in A549 cells exposed to 10(-5) M for 72 h, a concentration substantially higher than the concentration kill the H(37)Rv strain of M. tuberculosis. The compound 9u was found to be safe up to 10(-4) M if given for 24 h. The data reveal the therapeutic potential of compound 9u against M. tuberculosis without any having any cytotoxicity and genotoxicity responses. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3989918/ /pubmed/24748738 http://dx.doi.org/10.4103/0971-6580.128800 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kapoor, Ekta
Tripathi, Vinay
Kumar, Vivek
Juyal, Vijay
Bhagat, Sunita
Ram, Veerma
Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title_full Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title_fullStr Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title_full_unstemmed Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title_short Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549
title_sort cyto-genotoxicity assessment of potential anti-tubercular drug candidate molecule-trans-cyclohexane-1, 4-diamine derivative-9u in human lung epithelial cells a549
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989918/
https://www.ncbi.nlm.nih.gov/pubmed/24748738
http://dx.doi.org/10.4103/0971-6580.128800
work_keys_str_mv AT kapoorekta cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549
AT tripathivinay cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549
AT kumarvivek cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549
AT juyalvijay cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549
AT bhagatsunita cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549
AT ramveerma cytogenotoxicityassessmentofpotentialantituberculardrugcandidatemoleculetranscyclohexane14diaminederivative9uinhumanlungepithelialcellsa549